Boron Neutron Capture Therapy as a Cutting-Edge Strategy for Cancer Veterinary Patients.

Area of Science:

• Veterinary Medicine
• Oncology
• Radiation Therapy

Background:

• Cancer is a leading cause of death in pets, driving demand for advanced treatments.
• Conventional therapies like radiation have limitations in tumor targeting, affecting patient outcomes.
• Comparative Veterinary Oncology offers a platform for developing novel therapies with translational potential for human medicine.

Purpose of the Study:

• To highlight the significance of Comparative Veterinary Oncology in advancing cancer treatment strategies for both pets and humans.
• To review Boron Neutron Capture Therapy (BNCT) as a cutting-edge therapeutic approach for veterinary cancer patients.
• To discuss the potential of BNCT in improving the quality of life and survival rates for pets with cancer.

Main Methods:

• Review of existing literature on Boron Neutron Capture Therapy (BNCT).
• Analysis of experimental studies (in vitro and in vivo) and clinical trials involving BNCT in veterinary and human patients.
• Discussion of the principles and advantages of BNCT, including biological targeting and heavy ion radiation therapy.

Main Results:

• Boron Neutron Capture Therapy (BNCT) shows promise as an effective treatment for various solid tumors in pets.
• BNCT combines biological targeting with radiation therapy, offering improved tumor specificity compared to conventional methods.
• The application of BNCT in veterinary patients has yielded positive results, with potential for enhanced life expectancy and quality of life.

Conclusions:

• Comparative Veterinary Oncology is crucial for developing and refining novel cancer therapies like BNCT.
• BNCT represents a significant advancement in cancer treatment for pets, offering a viable alternative to conventional therapies.
• Further research and clinical application of BNCT in veterinary medicine can provide valuable insights and accelerate progress in human cancer treatment.